Literature DB >> 2031156

Counselling women with rheumatic disease--how many children are desirable?

M Ostensen1.   

Abstract

The interaction of pregnancy and the rheumatic diseases has been described for most of the inflammatory joint disorders. However, the patient response to the challenge of motherhood and child rearing has seldom been taken into consideration. The current study presents data derived from a patient inquiry on these issues. The results demonstrate that while a wish for children is present even in disabled patients, the number of children regarded feasible depends largely on coping strategies, external help and the patient's own resources. Information before pregnancy is crucial, but often insufficient. Counselling should rely not only on medical facts, but also on patient experience.

Entities:  

Mesh:

Year:  1991        PMID: 2031156     DOI: 10.3109/03009749109165287

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

1.  Impact of pregnancy on health related quality of life evaluated prospectively in pregnant women with rheumatic diseases by the SF-36 health survey.

Authors:  F Förger; M Østensen; A Schumacher; P M Villiger
Journal:  Ann Rheum Dis       Date:  2005-03-18       Impact factor: 19.103

Review 2.  Infertility - Prevention and Management.

Authors:  Emily C Somers; Wendy Marder
Journal:  Rheum Dis Clin North Am       Date:  2017-03-14       Impact factor: 2.670

3.  Reproductive trends in females with inflammatory joint disease.

Authors:  Marianne Wallenius; Kjell Å Salvesen; Anne K Daltveit; Johan F Skomsvoll
Journal:  BMC Pregnancy Childbirth       Date:  2016-05-31       Impact factor: 3.007

4.  Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus.

Authors:  In Je Kim; Hyoun-Ah Kim; Chang-Hee Suh; Yong-Wook Park; Hye-Soon Lee; So-Young Bang; Sang-Cheol Bae; Young Mo Kang; Won Kyung Lee; Hyesook Park; Jisoo Lee
Journal:  J Korean Med Sci       Date:  2016-03-29       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.